NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Decheng Capital

Decheng Capital

Menlo Park, Californiadecheng.com

Overview

Decheng Capital is a global life sciences venture capital firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence.

Year Founded

2012

Portfolio Companies

2

Investments

Decheng Capital investments
CompanyDateStageLead
CellaresJun 2026Series DCo-investor
Solve TherapeuticsNov 2025VC RoundCo-investor
Solve TherapeuticsDec 2024VC RoundCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.